The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator

Journal of Glaucoma

Volumn 15, Issue 5, 2006, Pages 426-431

  Mansberger, Steven L ^a,b   Cioffi, George A ^a  

^a DEVERS EYE INSTITUTE   (United States)

^b DEVERS EYE INSTITUTE   (United States)

Author keywords

Evidenced based medicine; Glaucoma; Ocular hypertension; Randomized clinical trials; Risk calculator

Indexed keywords

AGE DISTRIBUTION; CORNEA THICKNESS; DIABETIC PATIENT; EVIDENCE BASED MEDICINE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MEDICAL SPECIALIST; OPHTHALMOLOGIST; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS;

AGED; CROSS-SECTIONAL STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMOLOGY; PROBABILITY; RISK ASSESSMENT;

EID: 33748926767     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000212258.02702.0c     Document Type: Review

References (21)

1. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol. 1991;134:1102-1110.
2. Robin AL, Frick KD, Katz J, et al. The ocular hypertension treatment study: intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease? Arch Ophthalmol. 2004;122:376-378.
3. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720; discussion 829-830.
4. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713; discussion 829-830.
5. Cioffi GA, Liebmann JM. Translating the OHTS results into clinical practice. J Glaucoma. 2002;11:375-377.
6. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
7. Medeiros FA, Weinreb RN, Sample PA, et al. Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol. 2005;123:1351-1360.
8. Institute of Medicine: US Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001:337.
9. Ocular Hypertension Treatment Study slide set. Available at: http://vrcc.wustl.edu/ohts-results1.pdf. Accessed March 2004.
10. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 7th ed. New York: Wiley; 1999.
11. Kass MA, Hart WM Jr, Gordon M, et al. Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension. Surv Ophthalmol. 1980;25:155-162.
12. Hart W, Yablonski M, Kass M. Multivariate analysis of the risk of glaucomatous visual field loss. Arch Ophthalmol. 1979;97:1455.
13. Armaly M, Krueger D, Maunder L, et al. Biostastical analysis of the Collaborative Glaucoma Study: I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. 1980;98:2163-2171.
14. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA. 1995;274:1591-1598.
15. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley; 2000.
16. Devers OHTN to Glaucoma Risk Calculator. 2003. Available at: http://www.discoveriesinsight.org/glaucomarisk.htm. Accessed February 9, 2004.
17. Miglior S, Zeyen T, Pfeiffer N, et al. The European glaucoma prevention study design and baseline description of the participants. Ophthalmology. 2002;109:1612-1621.
18. Mansberger SL. A risk calculator to determine the probability of glaucoma. J Glaucoma. 2004;13:345-347.
19. Lichter PR. Variability of expert observers in evaluating the optic disc. Trans Am Ophthalmol Soc. 1976;74:532-572.
20. Weinreb RN, Friedman DS, Fechtner RD, et al. Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol. 2004;138:458-467.
21. Kass MA, Gordon MO, Kymes SM. Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice. Arch Ophthalmol. 2005;123:1021-1022.